MR编号 | SE/H/2192/001 |
---|
药品名称 | Peditrace Novum |
---|
活性成分 | - Copper chloride dihydrate 107.4 µg/ml
- Manganese chloride tetrahydrate 3.6 µg/ml
- Potassium iodide 2.57 µg/ml
- Sodium selenite 15.33 µg/ml
- Zinc chloride 1.04 mg/ml
|
---|
剂型 | Concentrate for solution for infusion |
---|
上市许可持有人 | Fresenius Kabi AB,
Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Ireland (IE)
- Estonia (EE)
- Austria (AT)
- Hungary (HU)
Peditrace Novum concentrate for solution for infusion - France (FR)
- Bulgaria (BG)
Peditrace - Spain (ES)
- Cyprus (CY)
Peditrace Novum concentrate for solution for infusion - Portugal (PT)
- Czechia (CZ)
Peditrace Novum - Italy (IT)
- Romania (RO)
Peditrace Novum concentrate pentru soluţie perfuzabilă - Germany (DE)
Peditrace Novum - Greece (GR)
- Slovakia (SK)
- Denmark (DK)
- Norway (NO)
- Slovenia (SI)
- Belgium (BE)
- Finland (FI)
Peditrace Novum - Malta (MT)
Peditrace Novum Concentrate for solution for infusion - Netherlands (NL)
- Poland (PL)
Peditrace Novum - Croatia (HR)
- Luxembourg (LU)
- Latvia (LV)
- Iceland (IS)
- Lithuania (LT)
-
|
---|
许可日期 | 2023/04/18 |
---|
最近更新日期 | 2025/02/05 |
---|
药物ATC编码 | - B05XA31 electrolytes in combination with other drugs
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|